Maltron International Limited,High accuracy bodyfat analyzers and EIT systems

BioScan-916 in clinical Management of Patients Undergoing Dialysis
 

BioScan-916 analysis can improve clinical management in patients with end stage Renal disease (ESRD) who are undergoing
dialysis. Intermittent fluctuation in hydration status and plasma salt concentration or the inability to excrete excess water is
characteristic in End-Stage Renal Disease Patients undergoing dialysis.

Depending on the efficiency of dialysis and patient, the alternation in fluid volume can range from oedema with cardiopulmonary
congestion to dehydration and hypotension. Rapid transcellular shift of water between the extracellular (ECW) and Intracellular
water (ICW) compartments occur during Haemodialysis (HD) due to the removal of 1 to 4 litres of fluid over and average period
of 4 hours.

In peritoneal Dialysis (PD) between 1 to 3 litres of fluid dwell either intermittently or continuously in the peritoneum, thus
producing segmental accumulation of dialysate.

This page is from maltronint.com